Banco Santander S.A. Purchases 939 Shares of Doximity, Inc. (NASDAQ:DOCS)

Banco Santander S.A. grew its position in Doximity, Inc. (NASDAQ:DOCS) by 6.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,794 shares of the company’s stock after acquiring an additional 939 shares during the period. Banco Santander S.A.’s holdings in Doximity were worth $843,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of DOCS. Farther Finance Advisors LLC raised its position in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. CWA Asset Management Group LLC bought a new position in shares of Doximity in the third quarter valued at about $486,000. Covestor Ltd raised its holdings in shares of Doximity by 441.9% in the third quarter. Covestor Ltd now owns 1,680 shares of the company’s stock valued at $73,000 after buying an additional 1,370 shares during the last quarter. Los Angeles Capital Management LLC raised its holdings in shares of Doximity by 6,242.6% in the third quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock valued at $28,359,000 after buying an additional 640,612 shares during the last quarter. Finally, Fountainhead AM LLC bought a new position in shares of Doximity in the third quarter valued at about $710,000. Institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Canaccord Genuity Group boosted their target price on shares of Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research note on Friday, February 7th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Truist Financial lifted their price objective on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research report on Thursday, November 14th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Down 2.8 %

Shares of NASDAQ DOCS opened at $64.09 on Monday. The stock’s 50 day moving average price is $62.80 and its 200-day moving average price is $51.82. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a market capitalization of $11.96 billion, a PE ratio of 64.09, a PEG ratio of 4.10 and a beta of 1.34.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 37.40% of the stock is owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.